4SC Expands Patent Protection for Epigenetic Anti-Cancer Compound

News   Jul 15, 2013

 
4SC Expands Patent Protection for Epigenetic Anti-Cancer Compound
 
 
 

RELATED ARTICLES

scNMT-seq Allows Analysis of Connections Between Nucleosomes, Methylation and Transcription

News

A new bioinformatics technique allows researchers to study three key processes inside the cell simultaneously.

READ MORE

Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the Body

News

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.

READ MORE

CRISPR Study Reveals Errors in Earlier Cancer Research

News

MELK, a protein previously thought to be implicated in cancer, has been shown to be unrelated to the disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE